Methadone. Methadone is usually taken as a pill or liquid mixed in juice. When taken in the right dose and amount, it greatly reduces withdrawal symptoms and cravings without causing intoxication. It can help people with opioid disorders feel more comfortable so they can concentrate better in counseling and perform daily chores. If a person takes other opioids like heroin, it can also block or lessen the effects of those opioids on the brain, thus preventing the person from getting “high.”
Methadone. The pharmacy will present the medicine to the service user in a suitably labelled receptacle and will provide the service user with water to facilitate administration and/or reduce the risk of doses being held in the mouth. If a service user’s dose is measured out in advance of their visit then suitable containers with lids should be used. These shall be individually labelled as per normal labelling regulations. Prior to disposal of these containers, all identifying labels shall be removed/anonymised.
Methadone. If the drug dispensed is a methadone compound:
(i) where methadone is prescribed for the purposes of treating a drug addiction, the maximum charge shall be the total of:
A. the prescription charge shall be: acquisition cost + markup + the compounding fee, if applicable [per Schedule “B” clause 1.2 (b) (ii) (B)] + dispensing fee for each seven (7) day period or a lesser period if the prescription is written for less than a seven (7) day period = prescription charge; and
B. the methadone managed care fee shall be: $7.50 per service, to a maximum of $52.50 in any seven-day period; or
C. the off-site methadone managed care fee shall be, subject to the restrictions set out in Schedule “G”: $7.50 per service, to a maximum of $52.50 in any seven-day period
(ii) where methadone is prescribed for the purposes of palliative pain management, the prescription charge shall be the total of: acquisition cost + markup + the compounding fee [per Schedule “B” clause 1.2 (b) (ii) (A)] + dispensing fee = prescription charge.
Methadone. The results will be returned to the Office of the Chief of Police who will be responsible for causing a copy to be mailed to the residence of each person tested. This process will be repeated once during each calendar quarter.
Methadone. If the drug dispensed is a methadone compound:
(i) where methadone is prescribed for the purposes of treating a drug addiction, the maximum charge shall be the total of:
A. the prescription charge shall be: acquisition cost + markup + the compounding fee, if applicable [per Schedule “B” clause 1.2 (b) (ii) (B)] + dispensing fee for each seven (7) day period or portion thereof = prescription charge; and
B. the methadone managed care fee shall be: $3.50 per service, to a maximum of $24.50 in any seven day period; or
C. the off-site methadone managed care fee shall be, subject to the restrictions set out in Schedule “G”: $3.50 per service, to a maximum of $24.50 in any seven day period
(ii) where methadone is prescribed for the purposes of palliative pain management, the prescription charge shall be the total of: acquisition cost + markup + the compounding fee [per Schedule “B” clause 1.2 (b) (ii) (A)] + dispensing fee = prescription charge.
Methadone. The following is not intended as a comprehensive guide to prescribing/dispensing methadone but aims to provide information to assist in the clinical assessment of prescriptions. Where there are concerns regarding the content of a prescription, the prescriber should be contacted. Drug Misuse and Dependence: UK guidelines on clinical management contains additional information on pharmacological management of opioid dependence. For patients who are new to methadone or who have returned after a break in treatment the following points must be taken into consideration: Patients should be commenced on methadone at the beginning of the week to allow time for tolerance to develop prior to the first take home dose being dispensed to cover pharmacy closure on Sunday. In Grampian, specialist services are closed at the weekend which may pose more of a problem should treatment issues arise. If the prescription starts towards the end of the week without prior communication, the prescriber should be contacted to discuss the reasoning and ensure they are aware of this risk. Most commonly, starting doses will range from 10 - 30mg. As a general rule of thumb, prescribers are advised to “start low and go slow.” Dose increases should be no greater than 510mg in any 24 hours and no greater than 30mg in a week. The prescriber must review the patient between dose increases. The average dose range for a stable patient will generally fall between 60mg and 120mg but higher doses may be necessary e.g. when patient has a heavy opioid dependency or when coprescribed an enzyme inducer or other medication that decreases serum levels of methadone. Supervised consumption is recommended for a minimum of 3 months after which time dispensing arrangements may be reviewed on an individual patient basis as per NHSG Substance Misuse Service Dispensing guidance. (Currently being reviewed by Xxxxxx Xxxxxx (March 2015)). (See also section 5.5)
Methadone. Methadone can be consumed directly from the dispensing bottle or decanted into a suitable container. If consumed from a bottle, it must be retained by the pharmacy following use and the patient’s identifiable data censored. The accredited Pharmacist or Pharmacy Technician shall observe the consumption of methadone by the patient. The patient should then be offered a drink of water (also helps prevent tooth decay) and engage in conversation with the patient. This is to ensure that the methadone has been swallowed. If this is the patient’s first dose of buprenorphine the Pharmacist should explain they must have waited at least 8 hours since their last heroin use or at least 24 hours since their last dose of methadone. This is to minimise the risk of precipitated withdrawal. A drink of water should be supplied to the patient to moisten the mouth (this aids dissolution of the tablet). It should be explained that the tablet(s) must be dissolved under the tongue to absorb the active ingredient and the patient should avoid swallowing (both the tablet(s) and saliva whilst dissolving). The accredited Pharmacist or Pharmacy Technician will then observe the patient placing the tablet(s) under the tongue to dissolve. The accredited Pharmacist or Pharmacy Technician can ask to observe the tablets in situ under the tongue before they begin to dissolve (to ensure tablets have been placed under the tongue). The patient should be observed until the tablet(s) have dissolved or at least a minimum of 3 minutes; the patient should then open his / her mouth to confirm the tablet(s) has dissolved. Supervision is most important in the first three minutes during which time the majority of the tablet will have dissolved and the risk of diversion greatly reduces. Methadone and Buprenorphine should not be dispensed when the Pharmacist considers the patient to be significantly intoxicated from drugs or alcohol. The patient should be asked to return back to the Pharmacy later in the day where possible. If this is not possible or they return later still intoxicated the dose should be withheld. The patient should have an explanation why their dose is being withheld and asked to return the following day. The risk of over dosage should be explained as well. If necessary and the Pharmacy is closed the next day then the take home dose will have to be withheld as well. In the event of a patient presenting intoxicated the Pharmacy will advise the prescribing agency the same working day and ide...
Methadone. 6. Contractor staff who respond to and/or witness medical emergencies involving the administration of intranasal naloxone must document details of the incident in the Unusual Occurrence/Incident Report form or other incident reporting form approved by DBH. Reports must be submitted immediately, but no later than within 24 hours, to the DBH contract monitor or designee. Staff should attempt to capture elements such as, but not limited to:
a. Individual’s respiration rate;
b. Quality of their respiration;
c. Individual’s pulse;
d. Individual’s pupil dilation;
e. Individual’s level of consciousness;
f. Condition the individual was found in;
g. Times events transpired; and
h. Name/accounts of any witnesses to the medical emergency.
7. Outcomes shall include:
a. Client understanding of available MAT options, and
b. Rates of MAT continuation from date of admission to date of discharge.
IV. ATTACHMENT III, Campaign Contribution Disclosure (SB 1439) is hereby added.
V. All other terms, conditions and covenants in the basic agreement remain in full force and effect. This Agreement may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, and such counterparts shall together constitute one and the same Agreement. The parties shall be entitled to sign and transmit an electronic signature of this Agreement (whether by facsimile, PDF or other email transmission), which signature shall be binding on the party whose name is contained therein. Each party providing an electronic signature agrees to promptly execute and deliver to the other party an original signed Agreement upon request. SAN BERNARDINO COUNTY Telecare Corporation (Print or type name of corporation, company, contractor, etc.) By Xxxx Xxxx, Chair, Board of Supervisors (Authorized signature - sign in blue ink) Dated: Name SIGNED AND CERTIFIED THAT A COPY OF THIS (Print or type name of person signing contract) DOCUMENT HAS BEEN DELIVERED TO THE CHAIRMAN OF THE BOARD Title Xxxxx Xxxxxx Clerk of the Board of Supervisors of San Bernardino County (Print or Type) By Dated: Deputy Address Approved as to Legal Form Reviewed for Contract Compliance Reviewed/Approved by Department Xxxx Xxxxxx, Deputy County Counsel Xxxxxxx Xxxxxx, Contracts Manager Xxxxxxxx Xxxxxxxx, Director Date Date Date
(1) One business entity has a controlling ownership interest in the other business entity;
(2) there is shared management and control between the entities; or
(3) a controlling owner...
Methadone. The assayed compounds are methadone and metabolite. A deuterated internal standard is used. Methadone and metabolite are extracted and specific ions are monitored on the GC/MS.
Methadone. Naltrexone (oral and long-acting injectable)
